1. Inicio
  2. Proyectos y Estudios
  3. ESTUDIO DE FASE 3B, DOBLE CIEGO, RANDOMIZADO, CONTROLADO CON PLACEBO, MULTICÉNTRICO QUE EVALÚA EL EFECTO DEL ÁCIDO OBETICÓLICO EN LOS RESULTADOS CLÍNICOS EN PACIENTES CON CIRROSIS BILIAR PRIMARIA.

ESTUDIO DE FASE 3B, DOBLE CIEGO, RANDOMIZADO, CONTROLADO CON PLACEBO, MULTICÉNTRICO QUE EVALÚA EL EFECTO DEL ÁCIDO OBETICÓLICO EN LOS RESULTADOS CLÍNICOS EN PACIENTES CON CIRROSIS BILIAR PRIMARIA.

Datos básicos

Código:
747-302
Protocolo:
747-302
EUDRACT:
2014-005012-42
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2016
Año de finalización:
2022
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

INTERCEPT PHARMACEUTICALS INC.

Resultados del Ensayo Clínico

HOW SHOULD I MANAGE HBV IN THE WAITLISTED PATIENT?

MARINA BERENGUER HAYM, J. FUNG

Capítulo de un Libro. 2017


"Posttransplant calcineurin inhibitors levels and intra-patient variability are not associated with long term outcomes following liver transplantation".

Di Maira T; (...); Berenguer M

Article. 10.1097/TP.0000000000002987. 2020


A multicenter study to assess the incidence of hepatocellular carcinoma recurrence after liver transplantation in patients treated with direct-acting antivirals for chronic hepatitis C

Gorgen, A; (...); Sapisochin, G

Meeting Abstract. 2018


A novel microRNA signature for cholestatic drugs in human hepatocytes and its translation into novel circulating biomarkers for drug-induced liver injury patients.

López-Riera M; (...); Jover R

Article. 10.1093/toxsci/kfz138. 2020


A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area.

Carvalho-Gomes Â; (...); Berenguer M

Article. 10.1371/journal.pone.0228351. 2020


Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems

Fernandez-Murga, ML; (...); Jover, R

Review. 10.1016/j.fct.2018.07.017. 2018


Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis

Diaz, FC; (...); Prieto, M

Article. 10.5604/16652681.1222114. 2016


Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives.

Gitto S; (...); Berenguer M

Editorial Material. 10.1155/2019/8691502. 2019


Alterations in carbohydrate metabolism in cirrhotic patients before and after liver transplant

Ramos-Prol A; (...); Merino-Torres JF

Article. 10.1016/j.diabres.2015.10.002. 2015


An evaluation of the robustness of organ-at-risk recommendations made by GEC/ESTRO according to interobserver variability: a single-center experience

Chicas-Sett R; (...); Perez-Calatayud J

Article. 10.5114/jcb.2016.61738. 2016


An objective definition for clinical suspicion of T-cell-mediated rejection after liver transplantation

Rodriguez-Peralvarez, M; (...); De la Mata, M

Article. 10.1111/ctr.13005. 2017


Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?

Tejedor, Marta, Selzner, Nazia, Berenguer, Marina

Article. 10.1097/TP.0000000000004163. 2022


Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation Study

Puchades, L; (...); Lai, JC

Article. 10.1097/TP.0000000000002025. 2018


ATP7B AND OTHER GENES RESULTING IN WILSON DISEASE (WD) PHENOTYPE

Sanchez-Monteagudo, A; (...); Berenguer, M

Meeting Abstract. 2019


Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy forHelicobacter pyloriinfection: Spanish data of the EuropeanHelicobacter pyloriRegistry (Hp-EuReg)

Nyssen, OP; (...); Gisbert, JP

Article. 10.1111/hel.12722. 2020


Circulating MicroRNAs: Dynamic Markers of Liver Transplant Injury.

Mas VR, Bardhi E, Berenguer M

Article. 10.1097/TP.0000000000003816. 2021


Clinical and molecular characterization of Wilson's disease in the Valencian Region

Sanchez-Monteagudo, A; (...); Espinos, C

Meeting Abstract. 2018


Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry

Ampuero, J; (...); Gomez, MR

Meeting Abstract. 10.1016/S0168-8278(18)31942-1. 2018


Clinical outcomes of patients delisted from thewaiting list of liver transplantation after interferon-free antiviral therapy

Pascasio, JM; (...); Londono, MC

Meeting Abstract. 10.1016/S0168-8278(17)30661-X. 2017


Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation

Pascasio, JM; (...); Londoño MC

Article. 10.1016/j.jhep.2017.08.008. 2017


CLINICAL PRESENTATION AND OUTCOMES OF DE NOVO HEPATITIS B VIRUS INFECTION AFTER LIVER TRANSPLANTATION IN SPAIN.

Pascasio Acevedo, Juan Manuel; (...); Manuel Sousa, Jose

Meeting Abstract. 2019


Combined Resistance and Endurance Training at a Moderate-to-High Intensity Improves Physical Condition and Quality of Life in Liver Transplant Patients

Moya-Najera, D; (...); Colado, JC

Article. 10.1002/lt.24827. 2017


Comparative effects of second-line therapy with obeticholic acid or fibrates in primary biliary cholangitis patients

Reig, Anna; (...); Pares, Albert

Meeting Abstract. 2020


Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry.

Stephens C; (...); Andrade RJ

Article. 10.1016/j.jhep.2021.01.029. 2021


Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline

Aller, R; (...); Romero-Gomez, M

Correction. 10.1016/j.gastrohep.2018.05.011. 2018


Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline

Aller, R; (...); Romero-Gomez, M

Review. 10.1016/j.gastrohep.2017.12.003. 2018


Controlling Diabetes After Liver Transplantation: Room for Improvement

Alvarez-Sotomayor D; (...); Berenguer M

Article. 10.1097/TP.0000000000001399. 2016


Corrigendum to "Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives".

Gitt S; (...); Berenguer M

Correction. 10.1155/2020/4305190. 2020

  • Open Access.

COVID-19 and liver transplantation

Di Maira T, Berenguer M

Editorial Material. 10.1038/s41575-020-0347-z. 2020


Critical review of HCC imaging in the multidisciplinary setting: treatment allocation and evaluation of response

Amorim J; (...); Martí-Bonmatí L

Review. 10.1007/s00261-020-02470-1. 2020


Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation.

Rodríguez-Perálvarez M; (...); Bernal-Bellido C

Article. 10.1111/ajt.17021. 2022


Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study

Aguilera, V; (...); Berenguer, M

Article. 10.1111/tri.13145. 2018


CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION

Carvalho-Gomes, A; (...); Aguilera, V

Meeting Abstract. 2021


Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation.

Carvalho-Gomes Â; (...); López-Labrador FX

Article. 10.1016/j.cellimm.2021.104455. 2022


Cytomegalovirus specific polyfunctional T-cells control CMV reactivation after liver transplantation

Carvalho-Gomes, A; (...); Aguilera, V

Meeting Abstract. 2021


Changing delta hepatitis patient profile: A single center experience in Valencia region, Spain

Hernandez-Evole, H, Briz-Redon, A, Berenguer, M

Article. 10.4254/wjh.v12.i6.277. 2020


Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.

Mínguez Sabater A; (...); Berenguer, Marina

Article. 10.1016/j.gastrohep.2021.03.017. 2022


CHARACTERISTICS AND IMPACT OF SEX IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM A CLASSICALLY LOW PREVALENCE AREA

Minguez, Alejandro; (...); Berenguer, Marina

Meeting Abstract. 2021


Characteristics, trends and outcomes of liver transplantation (LT) for primary sclerosing cholangitis (PSC) in female patients: analysis of the European Liver Transplantation Registry (ELTR)

Di Maira, T; (...); European Liver & Intestine

Meeting Abstract. 2021


Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry

Berenguer M; (...); European Liver Intestine Transplan

Article. 10.1097/TP.0000000000003542. 2021


Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.

Chen Q; (...); Quer J

Article. 10.1016/j.antiviral.2019.104694. 2020


Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects

Ampuero, Javier; (...); Romero-Gomez, Manuel

Article. 10.1111/liv.14898. 2021


Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting

Perricone, G; (...); European Liver Intestine Transpla

Article. 10.1111/liv.13878. 2018


Delisting of Liver Transplant Candidates with Chronic HCV Infection after Viral Erradication: Outcome 2 Years after Delisting. A European Study

Vinaixa, C; (...); Duvuox, C

Meeting Abstract. 10.1097/01.tp.0000542536.91165.49. 2018


Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

Belli LS; (...); European Liver and Intestine Association (ELITA)

Article. 10.1016/j.jhep.2016.05.010. 2016


Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study

Belli, LS; (...); Duvoux, C

Meeting Abstract. 10.1016/S0168-8278(17)30339-2. 2017


Development and Validation of Hepamet Fibrosis Scoring System-a Simple, Non-invasive Test to Identify Patients With Nonalcoholic Fatty liver Disease With Advanced Fibrosis.

Ampuero J; (...); Del Pozo Maroto E

Article. 10.1016/j.cgh.2019.05.051. 2020


Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)

Manzardo, C.; (...); Samuel, D.

Correction. 10.1111/ajt.15244. 2019


Disease Reversibility in Patients With Post-Hepatitis C Cirrhosis: Is the Point of No Return the Same Before and After Liver Transplantation? A Review

Vinaixa, C, Strasser, SI, Berenguer, M

Review. 10.1097/TP.0000000000001633. 2017


Distinct features of hepatitis delta in a Mediterranean setting

Hernandez-Evole, H, Berenguer-Haym, M

Meeting Abstract. 10.1016/S0618-8278(19)30486-4. 2019


Does Surgeon Fatigue Influence the Results of Liver Transplantation?

Bosca, A; (...); Lopez-Andujar, R

Article. 10.1016/j.transproceed.2018.03.139. 2019


DRESS cases included in the Spanish and Latin-American DILI registries: clinical phenotype and outcome

Medina-Caliz, I; (...); Andrade, RJ

Meeting Abstract. 10.1016/S0168-8278(18)31459-4. 2018


Early predictors of corticosteroid response in acute severe autoimmune hepatitis: A nationwide multicenter study

Tellez, Luis; (...); Albillos, Agustin

Article. 10.1111/apt.16926. 2022


Effect of season and sunlight on viral kinetics during hepatitis C virus therapy.

Hernandez-Alvarez, N; (...); Hernandez-Guerra, M

Article. 10.1136/bmjgast-2016-000115. 2017


Effectiveness and Safety of Sofosbuvir/Velpatasvir/ Voxilaprevir in Patients with Chronic Hepatitis C Previously Treated with DAAs.

Llaneras J; (...); Buti M

Article. 10.1016/j.jhep.2019.06.002. 2019


Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

Alonso, S; (...); Fernandez-Rodriguez, CM

Article. 10.1111/jvh.12648. 2017


Effectiveness of obeticholic acid (OCA) in southern European patients with primary biliary cholangitis (PBC) as a second line therapy. A multicenter, international, real-world cohort

Garcia-Buey, Luisa; (...); Fernandez Rodriguez, Conrado Manuel

Meeting Abstract. 2020


Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort

Calleja, JL; (...); Spanish Group for the Study of the Use of Direct-acting Drugs Hepatitis C Collab

Article. 10.1016/j.jhep.2017.01.028. 2017


Effectiveness, safety/tolerability of OBV/PTV/r DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.

Londoño MC; (...); García-Buey L

Article. 10.1371/journal.pone.0221567. 2019


EFFICACY AND SAFETY OF BUDESONIDE AS FIRST LINE TREATMENT IN PATIENTS WITH AUTOIMMUNE HEPATITIS: SPANISH MULTICENTER STUDY

Diaz-Gonzalez, Alvaro; (...); Carlota Londono, Maria

Meeting Abstract. 2021


Efficacy of second-line regimens in SPain: Results from the EuroPean Registry on H. Pylori management (HP-EuReg)

Caldas, M; (...); Gisbert, JP

Meeting Abstract. 2019


Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C

Forns X; (...); Van Solingen-Ristea R

Article. 2016


Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study

Forns, X; (...); Jessner, W

Article. 10.1111/tid.12696. 2017


Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.

Forns, Xavier; (...); Jessner, Wolfgang

Article. 2017


Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

Crespo, J; (...); Antolin, GS

Article. 10.17235/reed.2019.6700/2019. 2019


Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).

Crespo J; (...); Sánchez Antolín G

Article. 10.1016/j.gastrohep.2019.09.002. 2019


ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients

Belli, LS; (...); Strazzabosco, M

Review. 10.1016/j.jhep.2017.03.006. 2017


ELITA consensus statements on use of DAAs in liver transplant candidates and recipients.

Belli, Luca S; (...); ELITA board members

Guideline. 2017


Enhanced recovery after surgery programs improve short-term outcomes after liver transplantation-A systematic review and meta-analysis

Tinguely, Pascale; (...); Spiro, Michael

Article. 10.1111/ctr.14453. 2021


Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes.

Petrov PD; (...); Jover R

Article. 10.1007/s00204-019-02643-y. 2020


Equally Interchangeable? How Sex and Gender Affect Transplantation

Melk, A; (...); Berenguer, M

Review. 10.1097/TP.0000000000002655. 2019


Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25).

Ampuero J; (...); Romero-Gómez M

Correction. 10.1016/j.jhep.2020.06.018. 2020


Ertapenem neurotoxicity in liver transplantation.

Martinez Delgado, Sara; (...); Conde, Isabel

Article. 10.17235/reed.2021.8469/2021. 2022


European and American Temporal Trends and Outcomes in Liver Transplant (LT) Patients with Human Immunodeficiency Virus (HIV)

Campos-Varela, I; (...); Terrault, N

Meeting Abstract. 2017


European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain.

Caldas M; (...); Hp-EuReg Investigators

Article. 10.3390/antibiotics10010013. 2020


Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.

Gómez-Bravo M; (...); Santoyo J

Article. 10.17235/reed.2022.8549/2021. 2022


Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management

Jadoul, M; (...); Martin, P

Article. 10.1016/j.kint.2018.06.011. 2018


EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND

Berenguer, Marina; (...); Carbone, Marco

Meeting Abstract. 2021


Extrahepatic Autoimmune Comorbidities in Patients with Primary Biliary Cholangitis. Lack of Association with Prognosis and Therapeutic Response to Ursodeoxycholic Acid.

Reig, A; (...); Spanish Col Hai Register

Meeting Abstract. 2018


Fat and liver transplantation: clinical implications

Vinaixa, C, Selzner, N, Berenguer, M

Review. 10.1111/tri.13288. 2018


Fat, cancer, the gut-liver axis and rare liver diseases

Berenguer, Marina

Editorial Material. 2020

  • Open Access.

Fat, cancer, the gut-liver axis and rare liver diseases.

Berenguer M

Editorial Material. 10.1016/j.jhepr.2020.100189. 2020


Frailty and Sarcopenia in Acute-on-Chronic Liver Failure

Renau, LP; (...); Berenguer M

Article. 10.1002/hep4.1722. 2021


GENDER AND RACIAL DISCRIMINATION AMONG LIVER TRANSPLANTATION PROFESSIONALS: A SURVEY FROM ILTS EDI COMMITTEE

Andacoglu, Oya; (...); Selzner, Nazia

Meeting Abstract. 2021


Genetics of Wilson disease and Wilson-like phenotype in a clinical series from eastern Spain.

Sánchez-Monteagudo A; (...); Espinós C

Article. 10.1111/cge.13719. 2020


Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS).

Russo FP; (...); Polak WG

Article. 10.1016/j.jhep.2021.09.041. 2021


Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria

de la Varga, MF; (...); Castillo, MP

Meeting Abstract. 2021


Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.

Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria

Article. 10.1016/j.aohep.2022.100724. 2022


Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)

Calleja, JL; (...); Pineda, JA

Article. 10.1016/j.gastrohep.2018.07.010. 2018


HCV cirrhosis: liver volume as a non-invasive predictor of liver recovery post DAA treatment

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 10.1016/S0168-8278(17)31568-4. 2017


Heat stroke and fulminant hepatitis: Conservative management or liver transplant?

Ladrón Abia P; (...); Berenguer Haym MC

Letter. 10.1016/j.gastrohep.2020.11.004. 2021


Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice

Ampuero, J; (...); Gomez, MR

Meeting Abstract. 10.1016/S0168-8278(18)30415-X. 2018


Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies

Catala-Senent, Jose F.; (...); Garcia-Garcia, Francisco

Article. 10.1186/s13293-021-00368-1. 2021


Hepatitis C-related cirrhosis: Current status

Conde, I, Vinaixa, C, Berenguer, M

Review. 10.1016/j.medcli.2016.09.019. 2017


Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry

Medina-Caliz, I; (...); Spanish DILI Registry

Article. 10.1016/j.cgh.2017.12.051. 2018


High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

Mariño Z; (...); Forns, X

Article. 10.1111/liv.13470. 2017


HIV infection is not associated with increased cardiovascular (CV) risk in liver transplant (LT) recipients: a single centre comparative study

Vinaixa, C.; (...); Prieto, M.

Meeting Abstract. 2019


HIV Infection Is Not Associated with Increased Cardiovascular Risk in Liver Transplant Recipients: A Single Center Comparative Study

Herreras, J; (...); Berenguer, M

Meeting Abstract. 2018


Iberogast-Induced Severe Hepatotoxicity Leading to Liver Transplantation

Sáez-González E; (...); Berenguer M

Letter. 10.1038/ajg.2016.260. 2016


Immunosuppression in liver transplant.

Di Maira T, Little EC, Berenguer M

Review. 10.1016/j.bpg.2020.101681. 2020


Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT)

Saez-Gonzalez, E; (...); Berenguer, M

Article. 10.1111/liv.13618. 2018


Impact of the alveolar-arterial oxygen gradient on prognosis after liver transplantation in adults: a single-center experience

Ortega, AG; (...); Reyes, RL

Meeting Abstract. 10.1183/13993003.congress-2020.1917. 2020


Inadequate social support decreases survival in decompensated liver cirrhosis patients.

García Morales N; (...); Cubiella, Joaquin

Article. 10.1016/j.gastrohep.2022.04.006. 2022


Incidence and prognostic impact of cancer after liver transplantation

Gastaca, M; (...); Rodriguez-Peralvarez, M

Meeting Abstract. 2021


Incidence and prognostic impact of cancer after liver transplantation

Rodriguez-Peralvarez, Manuel; (...); Angel Gomez-Bravo, Miguel

Meeting Abstract. 2020


Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years

Ramos-Prol, A.; (...); Merino-Torres, J. F.

Article. 10.1007/s40618-017-0810-z. 2018


International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation

Tsochatzis, E; (...); Berenguer, M

Review. 10.1097/TP.0000000000002433. 2019


International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates

Terrault, NA; (...); Berenguer, M

Review. 10.1097/TP.0000000000001708. 2017


International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients

Terrault, NA; (...); McCaughan, GW

Review. 10.1097/TP.0000000000001704. 2017


International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients

Charlton, M; (...); Saliba, F

Review. 10.1097/TP.0000000000002147. 2018


International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients (vol 102, pg 727, 2018)

Berenguer, M

Correction. 10.1097/TP.0000000000002535. 2019


International Liver Transplantation Society Global Census report: a first look at the pediatric liver transplantation activity around the world

Lopez-Verdugo, F; (...); Pediat Liver Transplantation

Meeting Abstract. 2021


Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies

Puchades Renau, L, Berenguer, M

Review. 10.1111/hdi.12647. 2018


Kinetics of Cytomegalovirus Specific Polyfunctional T-Cell Responses Associated with Control of CMV Reactivation after Liver Transplantation.

Carvalho-Gomes, A; (...); Lopez-Labrador, FX

Meeting Abstract. 2018


Last Gasps of the Hepatitis C Virus Dragon: Direct Acting Antiviral Failures and Hepatitis C Virus-Positive Donors

Berenguer M

Article. 10.1002/lt.24520. 2016


Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice

Crespo J; (...); Calleja JL

Article. 10.1016/j.gastrohep.2015.04.002. 2015


LipidMS: An R Package for Lipid Annotation in Untargeted Liquid Chromatography-Data Independent Acquisition-Mass Spectrometry Lipidomics

Alcoriza-Balaguer, MI; (...); Lahoz, A

Article. 10.1021/acs.analchem.8b03409. 2019


Liver Transplantation for Alcoholic Liver Disease

Addolorato G; (...); Berenguer M

Review. 10.1097/TP.0000000000001156. 2016


Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)

Belli, LS; (...); ELITA EF-CLIF Working Grp

Article. 10.1016/j.jhep.2021.03.030. 2021


Liver volume as a predictor of functional improvement post DAA treatment

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 2017


Liver Volume as a Predictor of Functional Improvement Post-DAA Treatment

Di Maira, T; (...); Berenguer, M

Article. 10.1097/TP.0000000000001990. 2018


Liver Volume as a Predictor of Outcome after HCV Eradication in Cirrhotic Patients

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 2017


Liver Websites

Levitsky J, Berenguer M

Editorial Material. 10.1097/TP.0000000000001359. 2016


LOCATION AND ALLOCATION: INEQUITY OF ACCESS TO LIVER TRANSPLANTATION FOR PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE GRADE 3 (ACLF-3) ACROSS EUROPE.

Artzner, Thierry; (...); Jalan, Rajiv

Meeting Abstract. 2021


Location and allocation: inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in Europe.

Artzner, Thierry; (...); Jalan, Rajiv

Article. 10.1002/lt.26499. 2022


Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017.

Legendre C; (...); Guthoff M

Article. 10.1097/TP.0000000000002316. 2018


Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.

Heinemann M; (...); all the other contributing centers (www.eltr.org) and the European Liver and Int

Article. 10.1111/ajt.16864. 2022


Long-term outcomes of the octogenarian donor liver recipient: The era of the new centurion.

Schneider S; (...); Berenguer M

Article. 10.1111/ctr.13629. 2019


Long-term patient and graft survival after liver transplantation for autoimmune hepatitis

Heinemann, Melina; (...); Schramm, Christoph

Meeting Abstract. 2020


Long-term survival after liver transplantation for autoimmune hepatitis - results from the European Liver Transplant Registry.

Heinemann M; (...); Schramm C

Article. 10.1002/lt.25739. 2020


Long-term survival after living donor liver transplantation in primary sclerosing cholangitis

Liwinski, T; (...); Schramm, C

Meeting Abstract. 2021


Metabolic and biochemical phenotypes can distinguish different patterns of histological severity in biopsy-proven NAFLD

Gomez, EV; (...); Romero-Gomez, M

Meeting Abstract. 10.1016/S0168-8278(17)30584-6. 2017


Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?

Herreras Lopez, Julia; (...); Aguilera, Victoria

Article. 10.17235/reed.2022.8384/2021. 2022


Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity

Ampuero, J; (...); Gomez, MR

Meeting Abstract. 10.1016/S0168-8278(18)31941-X. 2018


Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes

Quintas, G; (...); Castell, JV

Article. 10.1007/s00204-021-03114-z. 2021


Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation.

Herreras J; (...); Berenguer M

Article. 10.1097/TXD.0000000000000934. 2019


Mitochondrial bioenergetics boost macrophages activation promoting liver regeneration in metabolically compromised animals.

Goikoetxea-Usandizaga, Naroa; (...); Martínez-Chantar ML

Article. 10.1002/hep.32149. 2021


MORE THAN A THIRD OF UNTREATED PATIENTS WITH CHRONIC HEPATITIS DELTA HAVE A DECREASE OR REACH UNDETECTABLE LEVELS OF HDV-RNA DURING NATURAL HISTORY

Palom, A; (...); Ferret, MAB

Meeting Abstract. 2020


Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.

Serrano MT; (...); Salcedo M

Article. 10.3389/ti.2022.10263. 2022


Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease

Bruguera M; (...); Mariño Z

Editorial Material. 10.1016/j.gastrohep.2016.06.003. 2016


Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease (vol 39, pg 571, 2016)

Bruguera, M; (...); Mariño Z

Correction. 10.1016/j.gastrohep.2017.02.005. 2017


Multidrug-resistant bacterial infections in patients with liver cirrhosis in a tertiary referral hospital

Bejar-Serrano, S; (...); Benlloch, S

Article. 10.1016/j.gastrohep.2018.07.017. 2019


Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers

Lopez-Riera, M; (...); Jover, R

Article. 10.1038/s41598-018-28854-4. 2018


Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related Cirrhosis.

Llovet, Laura-Patricia; (...); Londoño MC

Article. 10.1002/hep4.1889. 2022


Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.

Reig, A; (...); Pares, A

Article. 10.14309/ajg.0000000000001343. 2021


Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia

Forns X; (...); Everson G

Article. 10.1111/liv.12931. 2015


One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease

Palom, A; (...); Buti, M

Article. 10.1111/apt.16485. 2021


Out of Milan criteria and worse intetion to treat results at large liver transplant center

Lopez, JH; (...); Haym, MB

Meeting Abstract. 10.1016/S0168-8278(18)30613-5. 2018


Outcome of liver transplant candidates "delisted" after successful treatment of HCV infection

Perricone, G; (...); ELITA

Meeting Abstract. 2018


Out-of-Milan criteria and worse intention-to-treat results at a large liver transplant (LT) centre

Herreras, J; (...); Berenguer, M

Meeting Abstract. 2018


Out-of-Milan HCC criteria and worse intention-to-treat results following liver transplantation

Herreras, J.; (...); Berenguer, M.

Meeting Abstract. 2019


Overlap of primary biliary cholangitis and autoimmune hepatitis. Natural history and prognosis in a large cohort of patients from Spain

Reig, A; (...); Grp Registro Col-Hai Enfermedades

Meeting Abstract. 2019


Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance

Pallares, C; (...); Lopez-Labrador, FX

Article. 10.1016/j.jcv.2018.02.016. 2018


Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients

Vinaixa, C; (...); Prieto, M

Letter. 10.1002/lt.25297. 2018


Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant

Vinaixa, C, Berenguer, M

Editorial Material. 10.5604/16652681.1235470. 2017


PHYSICAL FRAILTY IN LIVER TRANSPLANTATION.

Puchades Renau L; (...); Berenguer Haym M

Review. 10.17235/reed.2020.7448/2020. 2021


Pilot validation study of a rapid test in oral fluid for population screening of hepatitis C virus infection

Pallares, C; (...); Berenguer, M

Meeting Abstract. 10.1016/S0168-8278(17)31165-0. 2017


Population screening using a point-of-care test reveals unexpectedly low prevalence of active HCV infection in Spain

Carvalho-Gomes, A; (...); Berenguer, M

Meeting Abstract. 2017


Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference

Berenguer, M; (...); van der Laan, LJW

Review. 10.1097/TP.0000000000003196. 2020


Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.

Castelló B; (...); Berenguer M

Article. 10.1016/j.aohep.2019.06.014. 2019


Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence

Song AT; (...); Samuel D

Article. 10.3748/wjg.v22.i18.4547. 2016


Predictive factors of response to corticosteroid therapy in acute severe autoinmune hepatitis: a national multicentric study

Sanchez Rodriguez, Eugenia; (...); Albillos, Agustin

Meeting Abstract. 2020


Predictors of hernia recurrence after Rives-Stoppa repair in the treatment of incisional hernias: a retrospective cohort.

Bueno-Lledó J; (...); Iserte J

Article. 10.1007/s00464-018-6597-y. 2019


Pregnancy and autoimmune hepatitis: presentation and outcomes

Llovet, LP; (...); Londono, MC

Meeting Abstract. 10.1016/S0168-8278(18)30683-4. 2018


Preoperative progressive pneumoperitoneum and botulinum toxin type A in patients with large incisional hernia

Bueno-Lledo, J; (...); Iserte, J

Article. 10.1007/s10029-017-1582-2. 2017


Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis.

Llovet LP; (...); Londoño MC

Letter. 10.1016/j.cgh.2018.12.030. 2019


Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline

Gordon, CE; (...); Martin, P

Article. 10.7326/M19-1539. 2019


Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.

Ampuero J; (...); Molina E

Letter. 10.1136/gutjnl-2021-325700. 2021


Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment

Pares, A; (...); Gil, A

Article. 10.17235/reed.2018.5665/2018. 2018


Profiles and clinical management of hepatitis C patients in Spain: disHCovery study (vol 28, pg 145, 2015)

Buti, Maria; (...); Esteban, Rafael

Article. 2015


Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence

Montalva EM; (...); Lopez-Andujar R

Article. 10.1016/j.transproceed.2016.07.033. 2016


Progrip self-gripping mesh in Rives-Stoppa repair: Are there any differences in outcomes versus a retromuscular polypropylene mesh fixed with sutures? A "case series" study.

Bueno-Lledo, J; (...); Iserte, J

Article. 10.1016/j.ijscr.2017.03.012. 2017


Pushing the donor limits: Deceased donor liver transplantation using organs from octogenarian donors

Díaz Jaime F, Berenguer, M

Article. 10.1002/lt.24841. 2017


Re: Tacrolimus Trough Concentrations after Liver Transplantation: .

Di Maira T; (...); Berenguer M

Letter. 10.1097/TP.0000000000003087. 2020


Real-Life Effectiveness and Safety of Velpatasvir/Sofosbuvir/Voxilaprevir for Previously Daa Treated Patients with Chronic Hepatitis C

Llaneras, J; (...); Buti, M

Meeting Abstract. 2018


Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.

Manuel Sousa J; (...); Manzanares A

Article. 10.1371/journal.pone.0225061. 2019


Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients

Aguiar, D; (...); Herrero, JI

Article. 10.12659/AOT.902523. 2017


Recommendations of everolimus use in liver transplant

Rubin Suarez, Angel; (...); Prieto Castillo, Martin

Review. 10.1016/j.gastrohep.2017.05.008. 2017


Remnant vital tissue following locoregional therapy for hepatocellular carcinoma: another player in the game

Rubin, A, Berenguer, M

Editorial Material. 10.1111/tri.13274. 2018


Reversion of disease manifestations after HCV eradication

van der Meer AJ, Berenguer M

Review. 10.1016/j.jhep.2016.07.039. 2016


Safety and Efficacy of Interferon-free Antiviral Treatment in Patients with MELD over 20

Vinaixa, C; (...); Berenguer, M

Meeting Abstract. 2017


Safety and efficacy of ombitasvir/paritaprevir/ritonavir +/- dasabuvir and +/- ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3-6)

Agarwal, K; (...); Forns, X

Meeting Abstract. 10.1016/S0168-8278(17)31461-7. 2017


Selective Indication of T-Tube in Liver Transplantation: Prospective Validation of the Results of a Randomized Controlled Trial

Lopez-Andujar, R; (...); Montalva, EM

Article. 10.1016/j.transproceed.2018.03.133. 2019


Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation

Lens, S; (...); Forns, X

Article. 10.1111/liv.13858. 2018


Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?

Selzner, N, Berenguer, M

Article. 10.1002/lt.25072. 2018


Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH

Ampuero, J; (...); Gomez, MR

Article. 10.1016/j.jhep.2020.02.028. 2020


Significant heterogeneity in the diagnosis and management of Wilson Disease (WD): results from a large Spanish Registry.

Berenguer, M

Meeting Abstract. 2017


Significant impact of new oral therapies against HCV on the waiting list for liver transplantation in Spain.

Berenguer, M, de la Rosa Rodríguez G, Dominguez-Gil, B

Letter. 10.1016/j.jhep.2018.06.011. 2018


SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA

de la Varga, MF; (...); Aguilera, V

Meeting Abstract. 2021


Simple score to assess cardiovascular risk post-liver transplantation

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 2021


Single-capsule bismuth-quadruple therapy: 3 or 4 times daily? Spanish Data from the European Registry on H. pylori Management (Hp-EuReg)

Nyssen, OP; (...); Calvet, X

Meeting Abstract. 2019


Stretching the boundaries for liver transplant in the 21st century

Trapero-Marugan, M, Little, EC, Berenguer, M

Review. 10.1016/S2468-1253(18)30213-9. 2018


Temporal Trends and Outcomes in Liver Transplantation for Recipients with Human Immunodeficiency Virus Infection in Europe and United States.

Campos-Varela I; (...); Terrault NA

Article. 10.1097/TP.0000000000003107. 2019


The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLD

Ampuero, J; (...); Gomez, MR

Meeting Abstract. 10.1016/S0618-8278(19)30234-8. 2019


The changing face of hepatology.

Berenguer M

Editorial Material. 10.1016/j.jhepr.2019.11.003. 2019


The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity

Ampuero, J; (...); HEPAmet Registry

Article. 10.1111/apt.15015. 2018


The Era of the New Centurion: Long Term Outcomes of the Octogenarian Liver

Diaz, FC; (...); Berenguer, M

Meeting Abstract. 2017


The first fifteen days of calcineurin inhibitors exposure do not predict post-transplant malignant outcomes

Di Maira, T; (...); Berenguer, M

Meeting Abstract. 2018


The ILTS Consensus Conference on NAFLD/NASH and Liver Transplantation: Setting the Stage

Burra, P, Berenguer, M, Pomfret, E

Article. 10.1097/TP.0000000000002507. 2019


The ILTS-SETH Consensus Conference on Extrahepatic Cancer and Liver Transplantation: Paving the Way.

Colmenero J, Berenguer M, Watt KD

Article. 10.1097/TP.0000000000003994. 2022


The impact of COVID-19 on liver transplant (LT) centers across the world during the first wave: a Multisociety Survey (EASL-ESOT/ELITA-ILTS)

Russo, FP; (...); Polak, W

Meeting Abstract. 2021


THE IMPACT OF DIRECT ACTING ANTIVIRALS ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC RETROSPECTIVE STUDY

Gorgen, A; (...); Sapisochin, G

Meeting Abstract. 2019


The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study

Gorgen, A; (...); Sapisochin, G

Article. 10.1097/TP.0000000000003115. 2020


The New Era of Hepatitis C Therapy in Liver Transplant Recipients

Little, EC, Berenguer, M

Article. 10.1016/j.cld.2016.12.012. 2017


THE PRESENCE OF METABOLIC SYNDROME BEFORE TRANSPLANTATION INCREASE THE RISK OF CARDIOVASCULAR EVENTS FOLLOWING LIVER TRANSPLANTATION

Herreras, J; (...); Aguilera, V

Meeting Abstract. 2021


The road map toward an hepatitis C virus-free transplant population.

Berenguer, M; (...); Samuel, D

Article. 10.1111/ajt.14976. 2018


Toxic epidermal necrolysis with severe hepatic involvement

Torres-Navarro, I; (...); Botella-Estrada, R

Letter. 10.1111/ddg.14110. 2020


Toxische epidermale Nekrolyse mit schwerer hepatischer Beteiligung.

Torres-Navarro I; (...); Botella-Estrada R

Letter. 10.1111/ddg.14110_g. 2020


Transplant Oncology in Primary and Metastatic Liver Tumor: Principles, Evidence and Opportunities.

Sapisochin G; (...); Mazzaferro V

Article. 10.1097/SLA.0000000000004071. 2020


Upper gastrointestinal bleeding as a complication of Brunner's gland adenoma. An unusual presentation

Herreras, J; (...); Bustamante-Balen, M

Letter. 10.1016/j.gastrohep.2018.05.020. 2019


Usefulness of magnetic resonance imaging in the postsurgical assessment of patients with inflatable penile prostheses

A. Pacheco Usmayo; (...); R. Rogel Bertó

Article. 10.1016/j.rxeng.2017.07.004. 2017


Usefulness of magnetic resonance imaging in the postsurgical assessment of patients with inflatable penile prostheses

Usmayo, AP; (...); Berto, RR

Article. 10.1016/j.rx.2017.04.004. 2017


Very early immunosuppression predicts the first-year renal function post liver transplantation

Di Maira, T.; (...); Berenguer, M.

Meeting Abstract. 2019


Wide variations in liver transplantation (LT) policies across Europe for patients with acute-on-chronic liver failure (ACLF) despite excellent post-LT survival: Results of a CLIF/ELITA collaborative study

Belli, Luca Saverio; (...); Arroyo, Vicente

Meeting Abstract. 2020


Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease

Sánchez-Monteagudo A; (...); Espinós C

Review. 10.3390/biomedicines9091100. 2021


Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse

Iborra, M; (...); Nos, P

Article. 10.1007/s10620-018-5429-1. 2019


Campos de estudio

Compartir